Table 1.
Primer | Forward | Reverse |
---|---|---|
GAPDH | TGTGTCCGTCGTGGATCTGA | TTGCTGTTGAAGTCGCAGGAG |
HPRT | AGTACAGCCCCAAAATGGTTAAG | CACAAACGTGATTCAAATCCCTG |
TBP | AAGAGAGCCACGGACAACTGC | CTTCACATCACAGCTCCCCAC |
PGC-1α | GCTCATTGTTGTACTGGTTGGATATG | CGTAGGCCCAGGTACGACAG |
Myoglobin | CCCTGGAGGGTTGAGCACGGT | AGGCCACCTGGTCCTGAAGGG |
SDHD | TCATGGGGACACCCTGCCGA | TCCACAGCATGGCAACCGCTC |
CS | GCCCAGCAGCTGTAGGATGACC | GGGGCCTGTCCCTGGCGTA |
MyH7 (Myosin Ib) | CCTTGGCACCAATGTCCCGGCTC | GAAGCGCAATGCAGAGTCGGTG |
MyH2 (Myosin IIa) | ATGAGCTCCGACGCCGAG | TCTGTTAGCATGAACTGGTAGGCG |
MyH1 (Myosin IIx) | GCTTCAAGTTTGGACCCACG | ACTTCCGGAGGTAAGGAGCA |
MyH4 (Myosin IIb) | GTGATTTCTCCTGTCACCTCTC | GGAGGACCGCAAGAACGTGCTGA |
Actg1 | TTCCTTCCTGGGCATGGAGT | GGCATACAGGTCTTTGCGGA |
Murf1 | GCAGCTCATCAAGAGCATTGT | CCAAAGTCAATGGCCCTCAA |
Atrogin-1 | GTGAGGACCGGCTACTGTGG | CAATCCAGCTGCCCTTTGTC |
Traf6 | GCGAGAGATTCTTTCCCTGACG | TTGGCACTGGGGACAATTCAC |
Calpain 1 | CTGGAGGCTGCAGGAACTAC | CTCCCGGTTGTCATAGTCGT |
Calpain 3 | CGAGAAACGAGGGGAAACCC | ACAGATCTCCATGTCGTCGC |
Calpastatin | TGGTGGTACAAGACGCATGTTA | ACATGTGGTCTGGAAGGCTG |
MARCKS | CCAGTTCTCCAAGACCGCAG | CATTCTCCTGCCCATTTGCTTTG |
Hsp70 | AGTCCGACATGAAGCACTGG | ATCTCCTCCGGGAAGAA |
Hsp90aa | TGTTCATTCAGCCACGATGC | AACTGGGCAATTTCTGCCTG |
Hsp90ab | CAGACCATGGTGAGCCCATT | CACCACTTCCTTGACCCTCC |
Stub1 | CCCTGATAAGAGCCCGAGTG | ACAAGTGGGTTCCGAGTGATG |
UFD2 | GTCACCAGACCGCAATCTCA | GGCTCCCAAACTAGACAACGA |
CryaB | ACGTGAAGCACTTCTCTCCG | ATGTTCGTCCTGGCGTTCTT |
TCP1 | TTAAACGGTCTCAGAGCGGA | GCAGCCATAACATTCTGGGA |
FKBP8 | GCTGGGAGACTGCGATGTTA | TGTATGGGCTCCTGCCCT |
skNAC | ACAGCCTCAGGCTGAGACAG | TTTGAAGTTCCTTTTGCCCAG |
Smyd1 | GCATCTTCCCCAACCTGGGCCT | GGGCCCGGAGCTCAATCCTCAT |
List of all primers employed for semi-quantitative RT-PCR analysis in this study. Commercially designed primers (Qiagen QuantiTect Primer Assays): Titin, Nedd4, Mical, MyoD1, and Cmya4